Related Experiment Video
Updated: Sep 23, 2025

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Diverse autophagy and apoptosis in myeloid leukemia cells induced by 20(s)-GRh2 and blue LED irradiation
Jianjian Zhuang1, Juxin Yin1,2, Chaojian Xu1
1Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, College of Life Science, Jilin University Changchun 130000 China lvsw@jlu.edu.cn.
Abstract:
Autophagy is an important mechanism for cell death regulation. To improve the anticancer effect during the treatment of leukemia and promote the apoptosis of leukemic cells, it is important to define the relationship between autophagy and apoptosis. A key bioactive compound in traditional Chinese medicine, 20(s)-Ginsenoside (GRh2), demonstrated an advancement in leukemia treatment. Blue LED therapy (BL) is a physical treatment method that can induce leukemic cell death. In this study, we tested the effect of 20(s)-GRh2, BL, and their combination (BL-GRh2) on the activation of leukemic cell apoptosis and autophagy. Both treatments, whether used individually or simultaneously, induce apoptosis through the induction of reactive oxygen species (ROS), disrupted mitochondrial membrane potential (MMP) and regulated the expression of apoptosis-related genes and proteins. Furthermore, using western blotting to analyze the autophagy markers LC3B and P62, we detected the activation of autophagy. In cells treated with autophagy inhibitor 3-MA, both autophagy and apoptosis were inhibited, either by BL alone or by BL-GRh2. However, apoptosis in 20(s)-GRh2-treated cells was enhanced. In cells treated with apoptosis suppressor Z-VAD-FMK, autophagy was inhibited in the BL and BL-GRh2-treated cells, although it was enhanced in cells treated with 20(s)-GRh2 alone. Moreover, we observed a stronger induction of apoptosis by BL-GRh2 in myeloid leukemia cells. Our data indicate that autophagy induced by different factors can play diverse roles on the same cells. Our results also indicate that the combination of traditional Chinese medicine with physical therapy may be a new strategy for anti-cancer therapy.
Insights
Combining traditional Chinese medicine (20(s)-Ginsenoside) with blue LED therapy enhances leukemia cell death by inducing apoptosis and modulating autophagy. This novel approach shows promise for leukemia treatment.
Area of Science:
- Oncology
- Cell Biology
- Traditional Chinese Medicine
Background:
- Autophagy and apoptosis are critical in regulating cell death, particularly in leukemia treatment.
- Understanding their interplay is key to improving anticancer efficacy.
- 20(s)-Ginsenoside (a traditional Chinese medicine compound) and Blue LED therapy (BL) show potential in leukemia treatment.
Purpose of the Study:
- To investigate the individual and combined effects of 20(s)-Ginsenoside (GRh2) and Blue LED therapy (BL) on leukemic cell apoptosis and autophagy.
- To elucidate the relationship between autophagy and apoptosis in response to these treatments.
- To evaluate the potential of combining GRh2 and BL as an anti-leukemia strategy.
Main Methods:
- Treatment of leukemia cells with 20(s)-GRh2, BL, and their combination (BL-GRh2).
- Assessment of apoptosis via reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) analysis, and apoptosis-related gene/protein expression.
- Analysis of autophagy markers (LC3B, P62) using western blotting.
- Utilizing autophagy inhibitor (3-MA) and apoptosis suppressor (Z-VAD-FMK) to dissect treatment mechanisms.
Main Results:
- Both 20(s)-GRh2 and BL individually and in combination induced apoptosis by increasing ROS and disrupting MMP.
- Autophagy was activated by BL and BL-GRh2, as indicated by LC3B and P62 levels.
- Inhibition of autophagy by 3-MA suppressed apoptosis in BL and BL-GRh2 treated cells, but enhanced apoptosis with 20(s)-GRh2 alone.
- Inhibition of apoptosis by Z-VAD-FMK suppressed autophagy in BL and BL-GRh2 treated cells, but enhanced autophagy with 20(s)-GRh2 alone.
- The combination therapy (BL-GRh2) showed a stronger induction of apoptosis in myeloid leukemia cells.
Conclusions:
- Autophagy plays a complex, context-dependent role in leukemia cell death induced by different stimuli.
- The combination of 20(s)-Ginsenoside with Blue LED therapy represents a promising new strategy for anti-leukemia therapy.
- This integrated approach highlights the potential of combining traditional medicine with physical therapy for cancer treatment.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

